Immediate Impact
12 standout
Citing Papers
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Current understanding and management of CAR T cell-associated toxicities
2024 Standout
Works of Melody Becnel being referenced
Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma.
2022
Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Melody Becnel | 130 | 51 | 42 | 51 | 25 | 172 | |
| Malvi Savani | 74 | 47 | 57 | 47 | 18 | 214 | |
| Eduardo Ríos | 73 | 69 | 26 | 104 | 32 | 214 | |
| Fauzia Ullah | 102 | 48 | 58 | 37 | 25 | 177 | |
| Lakhan Kashyap | 46 | 32 | 118 | 42 | 17 | 172 | |
| Jean‐Marc Hoffmann | 241 | 24 | 88 | 12 | 20 | 296 | |
| E. Seyrek | 79 | 31 | 46 | 72 | 22 | 260 | |
| Chetan Deshmukh | 57 | 38 | 20 | 19 | 34 | 162 | |
| Shibiao Sang | 127 | 19 | 31 | 73 | 35 | 252 | |
| Gaixiang Xu | 42 | 42 | 57 | 52 | 25 | 186 | |
| Marie-Émilie Dourthe | 41 | 26 | 35 | 16 | 24 | 125 |
All Works
Login with ORCID to disown or claim papers
Loading papers...